Managing Gestational Diabetes Safely In The COVID-19 Era

Gestational diabetes mellitus (GDM) requires careful control of maternal blood glucose while supporting fetal growth and preventing complications around birth. During the COVID-19 pandemic, that familiar goal became more complex. Clinic closures, infection-control measures, staff shortages, transport restrictions, and anxiety about exposure changed how many pregnant patients received screening and treatment.

The pandemic also accelerated practical methods that remain useful beyond emergency conditions. Remote consultations, home glucose monitoring, digital education, flexible appointment systems, and coordinated medication delivery helped maintain continuity of care. These approaches can complement in-person assessment rather than replace clinical judgment.

The scientific meetings associated with perinatal and neonatal medicine in 2020 reflected the importance of adapting pregnancy care during a period of international disruption. The FAOPS 2020 congress site provides historical context for that professional environment, including its focus on research, fetal health, and newborn outcomes.

Why The Pandemic Changed GDM Care

Routine GDM care depends on timely screening, nutritional counseling, glucose review, fetal surveillance, and preparation for delivery. COVID-19 affected every stage. Pregnant people sometimes postponed laboratory visits because of infection concerns, while hospitals redesigned pathways to separate potentially infectious patients from routine maternity services. Some patients also experienced reduced access to dietitians, diabetes educators, or community support.

The clinical consequences were uneven. A patient with mild, well-controlled hyperglycemia and reliable access to a glucometer might safely complete more appointments remotely. Someone with markedly elevated fasting glucose, previous adverse pregnancy outcomes, obesity, hypertension, or limited digital access generally needed closer face-to-face supervision. Risk-based care was therefore more appropriate than a single pandemic protocol for everyone.

Healthcare teams also had to distinguish pandemic-related changes from genuine deterioration. Reduced activity, stress, altered sleep, steroid treatment for COVID-19, and changes in food availability could raise glucose levels. Providers needed to ask about the whole living situation, including employment, childcare, food security, language needs, and the ability to isolate safely.

Screening And Diagnosis Under Infection-Control Measures

The standard diagnostic pathway usually involves glucose testing between 24 and 28 weeks, although earlier assessment is appropriate for people with known risk factors. During periods when laboratory access was restricted, some services used modified screening pathways. These could include a fasting plasma glucose, a random glucose measurement, or an HbA1c test in selected circumstances. Such alternatives may reduce visits, but they do not have identical sensitivity and should follow local guidance.

HbA1c is particularly limited in pregnancy. It can be influenced by changing red-cell turnover and may fail to identify post-meal hyperglycemia. A normal result does not always exclude GDM, especially when testing occurs later in pregnancy. Any modified approach should therefore document its limitations and include a plan for reassessment if symptoms, fetal growth concerns, or home glucose results suggest dysglycemia.

Telehealth can support history-taking and education, but diagnosis still depends on appropriate laboratory or validated home measurements. A remote appointment should confirm gestational age, prior diabetes history, medications, weight trends, blood pressure information where available, and symptoms of hyperglycemia or COVID-19. Clear safety-net instructions are essential if a patient cannot complete testing on schedule.

Nutrition, Activity, And Home Glucose Monitoring

Medical nutrition therapy remains the foundation of treatment for many patients with GDM. Advice should be individualized rather than reduced to a generic low-carbohydrate diet. Regular meals, high-fiber carbohydrates, adequate protein, vegetables, and appropriate portion sizes can improve postprandial control without compromising pregnancy nutrition. Severe calorie restriction or unsupervised fasting is inappropriate.

Movement is also useful when medically safe. Short walks after meals, light resistance exercises, and frequent changes of position may help reduce post-meal glucose. During periods of community transmission, indoor activity or home-based programs can provide alternatives. Patients with bleeding, preterm labor symptoms, ruptured membranes, placenta complications, or other obstetric restrictions need tailored advice from their maternity team.

Self-monitoring of blood glucose commonly includes fasting and post-meal readings, with the exact schedule determined by the care team. Patients should receive instruction on meter technique, hand washing, strip storage, target ranges, and what to do when a reading is unexpectedly high or low. Uploading readings through a secure platform can reduce unnecessary visits, but clinicians should review trends rather than reacting to one isolated value.

A structured log should include meal timing, medication doses, physical activity, illness, and relevant symptoms. This information helps distinguish persistent fasting hyperglycemia from occasional dietary excursions. It also allows clinicians to identify practical barriers, such as inability to afford test strips or difficulty obtaining prescribed food.

Medication Decisions And Maternal Fetal Safety

When lifestyle measures do not achieve target glucose levels, medication should not be delayed simply because in-person appointments are difficult. Insulin remains the preferred option in many guidelines because it does not cross the placenta in the same way as several oral agents and can be adjusted to the patient’s glucose pattern. Starting insulin requires education about injection technique, storage, hypoglycemia prevention, and dose adjustment.

Metformin is used in some health systems after counseling about its benefits, limitations, and placental transfer. Glyburide is less favored in many settings because of concerns about neonatal hypoglycemia and less predictable control. Local protocols, patient preferences, renal function, gestational age, and access to follow-up all influence the decision.

COVID-19 infection adds further considerations. Acute illness may reduce food intake while increasing glucose through inflammatory stress. Some patients may need more frequent monitoring, temporary medication changes, or assessment for dehydration and ketosis. A person taking insulin should receive a clear sick-day plan and know when to contact maternity, diabetes, or emergency services.

The pandemic also highlighted the relationship between maternal metabolic health and pregnancy outcomes. Research and clinical discussion about preterm birth prevention intersect with GDM care because poor glycemic control, hypertensive disease, and fetal growth abnormalities can influence decisions about surveillance and timing of delivery.

Fetal Surveillance And Planning For Birth

GDM management does not end with glucose readings. The pregnancy team may assess fetal growth, amniotic fluid, maternal blood pressure, and symptoms of preeclampsia. The intensity and timing of ultrasound or antenatal testing depend on glycemic control, medication use, comorbidities, and local standards. Remote care cannot replace these assessments when they are clinically indicated.

A birth plan should account for current glucose control, estimated fetal size, prior obstetric history, COVID-19 status, and the capacity of the maternity unit. GDM alone does not automatically require cesarean birth or early delivery. Decisions should balance the risks of continuing pregnancy against the risks associated with induction, operative birth, prematurity, and limited hospital resources.

Hospitals also needed plans for patients with active or recent SARS-CoV-2 infection. Isolation arrangements, personal protective equipment, newborn contact, feeding preferences, and support-person policies required clear communication before labor whenever possible. Policies changed over time, so families benefited from receiving updated instructions directly from their maternity service.

During labor, glucose monitoring and medication management should follow a documented protocol. After birth, neonatal staff may monitor the newborn for hypoglycemia, particularly when maternal diabetes was treated with insulin or glucose levels were poorly controlled. Early feeding and prompt assessment support a safer transition.

Postpartum Follow-Up And Long-Term Risk

After delivery, insulin resistance usually falls quickly, and medication often becomes unnecessary. That change should be supervised rather than assumed. Patients need advice about glucose symptoms, medication discontinuation, breastfeeding, recovery, and the timing of postpartum diabetes testing. A postpartum oral glucose tolerance test is commonly recommended because GDM signals a higher future risk of type 2 diabetes.

Pandemic-related disruption caused many postpartum tests to be missed. Remote reminders, laboratory appointments arranged near the patient’s home, and combined mother-and-baby visits can improve completion. An HbA1c test may be useful at certain intervals, but it does not always replace the recommended postpartum test, particularly soon after birth.

Long-term prevention should be practical and respectful. Gradual return to physical activity, balanced eating, weight management where appropriate, blood pressure care, and regular diabetes screening can reduce future risk. Counseling should recognize sleep deprivation, breastfeeding demands, mental health, finances, and the demands of caring for a newborn.

The child’s health also deserves attention. A pregnancy affected by GDM can be an opportunity to establish healthier family eating and activity patterns without assigning blame. Postpartum care is most effective when it remains connected to primary care rather than ending at the routine maternity check.

Practical Priorities For Resilient Care

A reliable service combines digital access with clinical safeguards. Patients should know who reviews their readings, how quickly they can expect a response, and which symptoms require urgent attention. Clinicians should also track missed tests and appointments instead of assuming that silence means stable health.

Useful priorities include:

• Provide every patient with a written glucose-monitoring and sick-day plan.
• Use telehealth for education and routine review while preserving essential examinations, laboratory tests, and fetal assessments.
• Screen early for barriers involving devices, internet access, transport, language, food, and medication costs.
• Escalate promptly when fasting or post-meal glucose remains above individualized targets.
• Arrange postpartum diabetes testing before discharge and connect the patient with primary care.

Clear communication reduces both avoidable exposure and dangerous delay. A phone call, secure message, or video visit should lead to a defined action, such as continuing the current plan, repeating a measurement, attending a clinic, or seeking emergency care. This makes hybrid care safer and more accountable.

The COVID-19 era demonstrated that gestational diabetes services can remain responsive during disruption when they are designed around risk, access, and continuity. Apply these principles in current maternity pathways, strengthen communication between obstetric and diabetes teams, and ensure that every patient receives timely support from diagnosis through postpartum follow-up.